Fig. 4From: Systematic pan-cancer analysis identifies SLC31A1 as a biomarker in multiple tumor typesSLC31A1 genetic alteration in various tumor types in TCGA. The frequency (a) and position of SLC31A1 mutation site b are derived from cBioPortalBack to article page